scholarly journals EPOS 4 Patients

2021 ◽  
Vol 0 (0) ◽  
pp. 1-57
Author(s):  
C. Hopkins ◽  
P. Surda ◽  
A. Walker ◽  
A. Wolf ◽  
M.M. Speth ◽  
...  

EPOS2020 is the 4th and most recent version of the European Position Paper on Rhinosinusitis and Nasal Polyps which was first published in 2005. It aims to provide the most up to date scientifically robust information on the topic published in the literature which has been critically analysed by an international group of clinicians drawn from all disciplines dealing with these problems together with patients. The guidelines offer evidence-based recommendations and care pathways for acute and chronic rhinosinusitis in both adults and children. Management of these diseases from the patients' perspective is an important part of EPOS2020. Not only is this included in the main document but, for the first time, we have produced a separate supplement dedicated to and in collaboration with patients, EPOS4Patients, which aims to provide information in an accessible format, to answer frequently asked questions about these diseases and their treatment options as well as including useful patient resources and websites. It has never been more important for patients to be actively involved in their care. Being well informed helps you to make the best decisions together with your doctor.

Situated at the crossroads of rhetoric and fiction, the genre of declamatio offers its practitioners the freedom to experiment with new forms of discourse. This volume places the literariness of Roman declamation into the spotlight by showcasing its theoretical influences, stylistic devices, and generic conventions as related by Seneca the Elder, the author of the Controversiae and Suasoriae, which jointly make up the largest surviving collection of declamatory speeches from antiquity. In so doing, it draws attention to the complexity of these texts, and maps out, for the first time, the sociocultural context for their composition, delivery, and reception. The volume’s chapters have been authored by an international group of leading scholars in Latin literature and rhetoric, and explore not only the historical roles of individual declaimers but also the physical and linguistic techniques upon which they collectively drew. In addition, the ‘dark side of declamation’ is illuminated by contributions on the competitiveness of the arena and the manipulative potential of declamatory skill. In keeping with the volume’s overall treatment of declamation as a literary phenomenon, a section has also been dedicated to intertextuality. This comprehensive, innovative, and up-to-date treatment provides thought-provoking analyses of Roman declamation, and therefore constitutes an essential volume for both students and scholars in the fields of Latin literature, Republican Roman history, and rhetoric.


2020 ◽  
Vol 2 (Supplement_3) ◽  
pp. ii22-ii22
Author(s):  
Yoshiki Arakawa ◽  
Junko Suga ◽  
Yukinori Terada ◽  
Kohei Nakajima ◽  
Masahiro Tanji ◽  
...  

Abstract Objective: Kyoto University Hospital has introduced the cancer genomic profiling tests, Oncoprime in 2015, Guardant360 in 2018, which are not under insurance coverage, FoundationOne CDx(F1CDx) and OncoGuide NCC Oncopanel system(NCC OP) in 2019, which received approval for insurance coverage for the first time in Japan. We investigated the results of cancer genomic profiling test under insurance coverage in our hospital. Methods: A special facility for the cancer genomic profiling tests was produced. To perform the cancer genomic profiling test, an outpatient must visit the facility three times (learning, ordering of the test, and getting the results). The expert panels decide the final test results and treatment options with the all information of the patients. Results: From November 2019 to March 2020, 51 and 9 patients were tested with F1CDx and NCC OP, respectively. 16 patients (31%) of F1CDX and 2 patients (22%) of NCC OP got treatment recommendations from the expert panels. However, only 5 patients (9.8%) of F1CDX and 1 patient (11%) of NCC OP received the treatments. The secondary finding suspecting germline mutations was found in 8 patients of F1CDX. Conclusion: After the approval the cancer genomic profiling tests with insurance coverage in Japan, it becomes easy for the patients to perform the test and get the genetic information of the tumor. However, it remains not easy to receive the recommended drugs because of several limitations of their usages.


Author(s):  
Nicholas Rebold ◽  
Dana Holger ◽  
Sara Alosaimy ◽  
Taylor Morrisette ◽  
Michael Rybak

2013 ◽  
Vol 22 (2) ◽  
pp. 329-331 ◽  
Author(s):  
Louise Hickson ◽  
Ariane Laplante-Lévesque ◽  
Lena Wong

Purpose The authors address 3 questions: (a) What is evidence-based practice (EBP), and why is it important for adults with hearing impairment? (b) What is the evidence about intervention options for adults who fail a hearing screening and are identified with hearing impairment? (c) What intervention options do adults choose when identified with hearing impairment for the first time? Method The 5 steps of the EBP process are discussed in relation to a clinical question about whether hearing aids and communication programs reduce activity limitations and participation restrictions compared with no treatment for adults who fail a hearing screening and are identified with hearing impairment. Results Systematic reviews of the evidence indicate that both hearing aids and communication programs reduce activity limitations and participation restrictions for this population and are therefore appropriate options. A study is then described in which these options were presented to 153 clients identified with hearing impairment for the first time: 43% chose hearing aids, 18% chose communication programs, and the remaining 39% chose not to take any action. Conclusion EBP supports the offer of intervention options to adults who fail a hearing screening and are identified with hearing impairment.


Phytotaxa ◽  
2021 ◽  
Vol 497 (2) ◽  
pp. 127-137
Author(s):  
XIAN-LIN GUO ◽  
MEGAN PRICE ◽  
WEI GOU ◽  
SONG-DONG ZHOU ◽  
XIN-FEN GAO ◽  
...  

The genus Similisinocarum Cauwet & Farille (Apiaceae, Apioideae), was first described by Cauwet & Farille in 1984, but it has been considered as a synonym of Sinocarum H.Wolff ex R.H. Shan & F.T. Pu. In this study, Simlisinocarum normanianum, the type species of Similisinocarum was found in China for the first time, and the molecular phylogenetic evidence based on ITS sequences reveals that Similisinocarum normanianum occupies an individual clade, which is sister to the clade comprising seven species of Acronema, Sinocarum, and Oreocomopsis in Acronema clade, the values of genetic distances (ITS) between Similisinocarum and Acronema, Similisinocarum and Oreocomopsis, Similisinocarum and Pternopetalum, Similisinocarum and Sinocarum are close (≥0.0916), while deviated from the values within Acronema, Sinocarum and Pternopetalum (≤0.0580). Morphologically, we found Similisinocarum normanianum develops reflex bracteoles with white membranous margin, petals with an entire margin and incurved apex, and mericarps with many vittae in the furrow (≥ 3) and commissure (6), which are distinguishable from other species of the Acronema clade. Consequently, results manifested in molecular and morphological analyses indicate that Similisinocarum should be treated as an independent genus distinct from Sinocarum.


2018 ◽  
Vol 31 (1) ◽  
pp. 56-58
Author(s):  
Konstantinos N Fountoulakis ◽  
Kyriakos Souliotis

AbstractRecently the Norwegian Health Minister ordered the creation of medication-free treatment wards as a result of the lobbying by patients’ groups and activists. The idea behind this is that patients should have the right to choose their treatment, but for the first time, with this arrangement, the user/patient does not choose between treatment options; he literally determines by himself what efficacious treatment is. In our opinion this is another step towards a ‘reverse stigma’ which denies patients the right to be considered as such and eventually kicks them out of the health care system, deprives them of the right for proper treatment and care and instead puts them at the jurisdiction of the much cheaper and ineffective social services.


Literary Fact ◽  
2021 ◽  
pp. 238-256
Author(s):  
Igor A. Vinogradov

For the first time, an analytical review of all, without exception, censorship stories of N.V. Gogol’s works is presented. An objective picture of Gogol's relationship with the censorship is being recreated. The findings of the study allow, with good reason, to judge about the interference of censors in the writer's works in a fundamentally different way, in comparison with the ideas offered by literary criticism of the previous period without solid evidence. Based on a thorough analysis, involving numerous archival sources, the common, stereotypical opinions about the extremely negative role of censorship in Gogol’s fate are being revised. The most significant negative result among all censorship interventions in Gogol's works was the activity of the censor of Westernizing views, opposed to the government, a professor at St. Petersburg University, A.V. Nikitenko. It is the numerous reductions of Nikitenko, И.А. Виноградов. Произведения Н .В. Гоголя и цензура 255 a friend of V.G. Belinsky, in Gogol's religious and patriotic book “Selected Passages from Correspondence with Friends” that the writer called “censorship murder”. No less significant was the intervention of the liberal censor in the texts of “Dead Souls”, “Theatrical Travel after the Presentation of a New Comedy” and other works of the writer. It is concluded that, with the exception of this “intrigue” against Gogol by the censor Nikitenko, on the whole Gogol's texts encountered relatively insignificant difficulties in censorship.


Sign in / Sign up

Export Citation Format

Share Document